96. Crohn disease Clinical trials / Disease details

Clinical trials : 2,400 /  Drugs : 1,391 - (DrugBank : 267) / Drug target genes : 170 - Drug target pathways : 215

  
2 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT05039411
(ClinicalTrials.gov)		January 1, 20221/9/2021Safety of Allogeneic Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) to Treat Perianal Fistulas Patients With Crohn's DiseaseA Phase I Study of the Safety of Allogeneic Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) for Perianal Fistulas in Patients With Crohn's DiseasePerianal Fistula Due to Crohn's Disease;Fistula in AnoBiological: Human umbilical cord mesenchymal stem cells (UC-MSCs)CryoCord Sdn BhdUniversity of MalayaNot yet recruiting18 YearsN/AAll7Phase 1Malaysia
2NCT02445547
(ClinicalTrials.gov)		June 201213/5/2015Umbilical Cord Mesenchymal Stem Cell Treatment for Crohn's DiseaseUmbilical Cord Mesenchymal Stem Cell Treatment for Crohn's Disease: A Randomized Controlled Clinical TrialCrohn DiseaseOther: UC-MSCs by peripheral intravenous infusion;Drug: received hormone maintenance therapyFuzhou General HospitalShaanxi Provincial People's HospitalCompleted18 Years70 YearsAll82Phase 1/Phase 2China